Navigation Links
Bionovo to Present at Wall Street Analyst Forum's 20th Annual Institutional Investor Conference
Date:3/18/2009

EMERYVILLE, Calif., March 18 /PRNewswire-FirstCall/ -- Bionovo, Inc. (Nasdaq: BNVI), a drug discovery and development company focused on the unmet needs in women's health and oncology, today announced that Isaac Cohen, Chairman and CEO of Bionovo, will be presenting at the Wall Street Analyst Forum's 20th Annual Institutional Investor Conference at 9:50 a.m. EDT on March 25, 2009. The event will be held at the University Club in New York City.

Analysts and portfolio managers can access a live webcast of the presentation by visiting www.analyst-conference.com and clicking on the analyst/pm registration tab. A replay will be available for 30 days following the conference.

Bionovo is on the leading-edge of developing a new class of drugs that address important conditions in women's health relating to menopausal issues and breast cancer. Bionovo has a number of drug candidates in various clinical trial stages, which the Company believes have significant future market opportunities.

Some of the recent key developments for Bionovo's drug candidates include:

MF101

  • An independent physician survey shows strong evidence that, if approved, Menerba(TM) (MF101) could become first-line treatment for menopausal symptoms. This suggests that Menerba could take a leading position in a multi-billion dollar market.
  • Bionovo announced that it has developed a novel analytical 2-dimensional liquid chromatography mass spectrometry-based (LC/LC-MS/MS) multiplexing platform that allows for the rapid, specific, sensitive automated quantification of the active pharmaceutical compounds of Menerba. If applied to botanical drug product production, this technique should facilitate exquisit
    '/>"/>

SOURCE Bionovo, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Bionovo Announces Closing of Public Offering of Common Stock
2. Bionovo Describes a New Class of Therapeutic Compounds
3. Bionovo Announces 2007 Financial Results and Highlights
4. Bionovo to Present at the Cambria Capital Investor Meeting
5. John D. Baxter, M.D. Joins Bionovos Board of Directors
6. Bionovo to Present at the Rodman & Renshaw 10th Annual Global Investment Conference
7. Bionovo to Present Recent Findings of BN108, its Anticancer Agent, at the 31st Annual San Antonio Breast Cancer Symposium
8. Willa A. Hsueh, M.D., Joins Bionovos Scientific Advisory Board
9. Bionovo Announces Cost Control Measures Taken
10. Bionovo Announces Presentation at the National Cancer Institute
11. Jan Ake Gustafsson, M.D., Ph.D., Joins Bionovos Scientific Advisory Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... HOUSTON, Dec. 16 OrthoAccel Technologies, Inc., ... is an acceleration device to enhance orthodontics, announced ... in the UK. Ms. Davies has spent ... in the dental industry, most recently for nine ... Technology , makers of Invisalign . ...
(Date:12/16/2009)... 16 New research published online, ... in pistachios, and molecules present in pistachios, ... decreases levels of an inflammatory marker known ... 2). Inflammation is a complex biological response ... irritants, and it underlies functional changes associated ...
(Date:12/16/2009)... Dec. 16 Quantros, Inc., a leading ... services solutions for the healthcare industry, announces the ... Quantros has named software industry veteran Michael Tulloch, ... will work from the company,s new Marlborough, MA ... a natural one," explains Tulloch. "Quantros has been ...
(Date:12/16/2009)... (BUSM) Pulmonary Center has received a two-year $1.4 ... Blood Institute to derive stem cells and lung ... Darrell Kotton, MD, associate professor of medicine and ... of medicine, are the principal investigators of this ... a multicenter investigative team of five Boston University ...
(Date:12/16/2009)... strongly indicates that wellness programs have a positive impact on ... ... Minneapolis, MN (PRWEB) December 16, 2009 -- A ... of employers have improved employee participation in health and wellness ... survey, conducted by Hallmark Insights, a leader in incentive-driven health ...
Breaking Medicine News(10 mins):Health News:Top-performing Sales Manager Joins OrthoAccel Technologies, Inc. in the United Kingdom 2Health News:Top-performing Sales Manager Joins OrthoAccel Technologies, Inc. in the United Kingdom 3Health News:Top-performing Sales Manager Joins OrthoAccel Technologies, Inc. in the United Kingdom 4Health News:New Study Reveals Pistachios Have Anti-Inflammatory Properties 2Health News:New Study Reveals Pistachios Have Anti-Inflammatory Properties 3Health News:Safety and Quality Software Developer Quantros, Inc. Launches Healthcare IT Consulting Division 2Health News:Boston University School of Medicine's pulmonary center receives $1.4 million grant 2Health News:Hallmark Insights' Employer Survey Reveals Cost-Savings Benefits of Health & Wellness Programs 2
... blunt, non-penetrating hit to the chest from a baseball or hockey puck ... The condition, commotio cordis and its prevention were investigated in the March/April ... ... February 24, 2009 -- A blunt, non-penetrating hit to the chest from ...
... among women is associated with a statistically significant increase in ... the cancers of the breast, liver, rectum, and upper aero-digestive ... online issue of the Journal of the National Cancer ... has been known about the impact of low to moderate ...
... reduces the long-term risk of disease recurrence and deaths ... not take tamoxifen, according to trial data reported in ... of the National Cancer Institute. , Systematic reviews ... reduce the risk of disease recurrence and death due ...
... sent to a cardiologist to go through a standard battery ... of coronary artery disease which is the most common cause ... men, and these women are sent home with little more ... of similar symptoms and are more likely to develop future ...
... Diagnosing acute stroke is a high-pressure decision. The speed ... Early treatment can stop brain damage, but if treatment ... of bleeding in the brain. , Because of this ... enzyme known as tissue plasminogen activator (tPA)is usually reserved ...
... Mass. (Feb 23, 2009) Postpartum depression is a ... of new mothers. Some of the causes might include ... of social, financial or emotional support. Left untreated, it ... mother but on her child,s development. , ...
Other Medicine News:Health News:Study Shows Simple Measures May Help Prevent Sudden Death Event in Young Athletes 2Health News:Million women study shows even moderate alcohol consumption associated with increased cancer risk 2Health News:Goserelin improves long-term survival in premenopausal women with early breast cancer 2Health News:Cardiologists initiate STILETTO study to investigate treatment options for women with chest pain 2Health News:Stroke treated significantly faster and just as safely by medical residents 2Health News:Stroke treated significantly faster and just as safely by medical residents 3Health News:Diabetes a risk factor for postpartum depression 2
(Date:12/15/2009)... Dec. 15 Sonic Innovations, Inc. (Sonic), ... and solutions, donated $10,000 to its local Feeding ... 14, 2009. ,, Sonic Innovations President Paul Wennerholm ... America member, the Utah Food Bank, at the ... also participated in an office food drive and ...
(Date:12/15/2009)... DAYTON, Ohio, Dec. 15 Robbins & Myers, ... it will release results for its fiscal 2010 first ... on Wednesday, January 6, 2010. A live ... at 2:30 p.m., ET. Peter C. Wallace, ... Vice President and Chief Financial Officer, will be discussing ...
(Date:12/15/2009)... Services, Inc. (NYSE: WST ) today announced ... the first-quarter 2010 cash dividend of $0.16 per share. ... to shareholders of record on January 20, 2010. ... global manufacturer of components and systems for injectable drug ... and disposable components used in syringe, IV and blood ...
Breaking Medicine Technology:Sonic Innovations, Inc. Donates $10,000 to Feeding America 2BioMed Realty Announces Results of Tender Offer for its Exchangeable Notes 15116 1BioMed Realty Announces Results of Tender Offer for its Exchangeable Notes 15116 2BioMed Realty Announces Results of Tender Offer for its Exchangeable Notes 15116 3Waters Ships First Units of SYNAPT G2 Mass Spectrometer 15114 1Waters Ships First Units of SYNAPT G2 Mass Spectrometer 15114 2FDA Launches Orphan Drug Workshop at KGI 6860 1FDA Launches Orphan Drug Workshop at KGI 6860 2
... File NDA in Second Quarter of 2008 -, ... WPI ), a leading specialty pharmaceutical,company, announced positive results ... (OTG) in patients with overactive bladder (OAB). The,study met ... episodes, and secondary endpoints of reduction in frequency,and increases ...
... Fovea Pharmaceuticals SA, which, last,December 2007, ... today announced that,its product, Recombinant human rod-derived ... Orphan Medicinal Product from the,European Commission, following ... the Evaluation of Medicinal Products (EMEA) Committee ...
Other Medicine Technology:Watson Announces Positive Results From Its Pivotal Study of Oxybutynin Topical Gel for the Treatment of Overactive Bladder 2Watson Announces Positive Results From Its Pivotal Study of Oxybutynin Topical Gel for the Treatment of Overactive Bladder 3Watson Announces Positive Results From Its Pivotal Study of Oxybutynin Topical Gel for the Treatment of Overactive Bladder 4Watson Announces Positive Results From Its Pivotal Study of Oxybutynin Topical Gel for the Treatment of Overactive Bladder 5Fovea Pharmaceuticals Receives Orphan Drug Designation from EC for RdCVF for the Treatment of Retinitis Pigmentosa 2Fovea Pharmaceuticals Receives Orphan Drug Designation from EC for RdCVF for the Treatment of Retinitis Pigmentosa 3
The pediatric blanket provides full coverage for pediatric patient care. The generous size and versatility of these blankets include extra material for the shoulders and feet. The foot drape also red...
The Pediatric ThermoWrap™ is designed to fit the proportions of your young patient and wraps around the entire body, without interfering with the sterilized area of operation....
Cocoon Disposable Patient Warming Blankets are specially designed to prevent hypothermia and maintain normothermia in your patients. The soft warm coloured material is strong and resists tearing and ...
The design of the large pediatric underbody blanket conveniently warms the large child or small adult patient while allowing full access for surgeons and staff....
Medicine Products: